Early Insights From Clinical Trials of Typhoid Conjugate Vaccine

Neuzil, Kathleen M, Basnyat, Buddha, Clemens, John D, Gordon, Melita A ORCID: 0000-0002-0629-0884, Patel, Priyanka D, Pollard, Andrew J, Shakya, Mila and Qadri, Firdausi
(2020) Early Insights From Clinical Trials of Typhoid Conjugate Vaccine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 (Supple). S155 - S159.

[img] Text
ciaa370 (1).pdf - OA Published Version

Download (2MB) | Preview


Clinical trials of typhoid conjugate vaccine (TCV) are ongoing in 4 countries. Early data confirm safety, tolerability, and immunogenicity of typhoid conjugate vaccine, and early efficacy results are promising. These data support World Health Organization recommendations and planned country introductions. Forthcoming trial data will continue to inform programmatic use of typhoid conjugate vaccine.

Item Type: Article
Uncontrolled Keywords: clinical trials, conjugate vaccine, typhoid, TyVAC
Depositing User: Symplectic Admin
Date Deposited: 01 Sep 2020 09:47
Last Modified: 23 Jul 2021 11:42
DOI: 10.1093/cid/ciaa370
Open Access URL: https://doi.org/10.1093/cid/ciaa370
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3099534